Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,776 across all filing types
Latest filing 2021-06-29 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
金宇生物技术股份有限公司关于股东股份质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a significant shareholder (内蒙古金宇生物控股有限公司) of the company 金宇生物技术股份有限公司. It details the number of shares pledged, the proportion of total shares, pledge dates, and assurances about the impact on company control and operations. There is no financial statement, audit, or management discussion. The document is a regulatory disclosure about share pledge, which fits the category of Regulatory Filings (RNS) as it is a compliance announcement about share pledge status and does not fit other more specific categories like Major Shareholding Notification (MRQ) because it focuses on pledge rather than ownership change. The document length is short (2072 characters), and it is not an announcement of a report publication but a standalone disclosure. Therefore, the best classification is Regulatory Filings (RNS).
2021-06-29 Chinese
金宇生物技术股份有限公司2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from a company regarding the implementation of its 2020 annual dividend distribution plan. It details the dividend per share, relevant dates for dividend registration, ex-dividend, and payment, as well as tax treatment for different types of shareholders. The document references the approval of the dividend plan at the 2021 shareholders' meeting and provides detailed instructions on dividend distribution. It does not contain full financial statements or comprehensive financial performance data, but rather focuses on dividend payment details. The document length is about 3,094 characters, which is relatively short and typical for a dividend announcement. Therefore, this document fits the category of a Notice of Dividend Amount (DIV).
2021-06-15 Chinese
经世律师事务所关于金宇生物技术股份有限公司差异化分红事项之法律意见书
Regulatory Filings
2021-06-15 Chinese
经世律师事务所关于金宇生物技术股份有限公司2020年年度股东大会的法律意见书
Regulatory Filings
2021-05-21 Chinese
金宇生物技术股份有限公司2020年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2020 Annual General Meeting (AGM) resolution announcement for 金宇生物技术股份有限公司. It details the date and location of the AGM, attendance, voting results on various proposals including the 2020 annual report, financial report, profit distribution plan, and other corporate matters. It also includes legal witness statements confirming the validity of the meeting and voting procedures. The document is a formal announcement of the voting results and resolutions passed at the AGM, not the full annual report or financial statements themselves. The length is about 4149 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-05-21 Chinese
金宇生物技术股份有限公司关于召开2020年年度股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2020 Annual General Meeting (AGM) of 金宇生物技术股份有限公司. It includes information about the date, voting methods, meeting agenda, and instructions for shareholders to participate. It does not contain the actual annual report or financial statements but rather serves as a notice and guidance for the upcoming AGM. The document length is under 5,000 characters and primarily serves as a meeting notice rather than the report itself. Therefore, it fits the category of AGM Information (AGM-R).
2021-05-14 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.